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 ABSTRACT 
Aging is accompanied by a disruption in various homeostatic networks 
including those devoted to maintaining protein conformation and integrity. 
Collectively this maintenance is referred to protein homeostasis or proteostasis. 
Growing evidence suggests that promoting proteostasis may not only be 
beneficial for protein aggregation-related disorders but may also influence 
normal aging. We have investigated various pharmacological means of 
promoting the proteostatic network and the effects on healthspan and longevity 
in the nematode Caenorhabditis elegans. 
Here we show that known amyloid binding compounds can prevent 
protein aggregation and extend lifespan in C. elegans. We report that the widely 
used amyloid-binding compound, Thioflavin-T not only adheres to Amyloid-β 
(Aβ) but also inhibits its misfolding or aggregation, thereby delaying the 
accompanying disease state in a C. elegans model of Alzheimer’s Disease (AD). 
Our data suggests that Thioflavin-T can prolong the vitality and lifespan of wild 
type (WT) C. elegans by stabilizing the proteostatic machinery. Additionally, we 
identified three other compounds related to Thioflavin-T that also extend 
lifespan. Interestingly, these other compounds are known to chelate copper and 
iron, two metals implicated in several aggregation-related disorders (Paper I).  
Many age-related protein aggregation neurodegenerative disorders 
(NDs) are accompanied by alterations in levels of various metals such as iron 
and copper. Whether these metals are a cause or consequence of ND is not well 
understood. In a characterization of metal composition (the metallome) with age 
we show that normal aging of C. elegans is accompanied by accumulation of 
calcium, iron, copper and manganese. Additionally, we found that increased 
dietary iron enhances toxicity in both Aβ and PolyQ-associated models of 
protein aggregation. We were able to reduce endogenous iron levels in C. 
elegans and found that this ameliorated various models of proteotoxic disease. 
Moreover, we show that CaEDTA exposure increases healthspan and lifespan in 
WT animals. Taken together, our findings suggest that metal accumulation is an 
inherent part of the aging process and likely destabilizes the proteostasis of the 
organism (Paper II).  
By using a C. elegans model for proteotoxicity we were able to screen a 
large natural library for additional drugs that could potentially enhance the 
healthspan and lifespan of C. elegans. Subsequently, we investigated the effects 
of 5-fluoro-2-deoxyuridine (FUdR) in models of protein aggregation. We have 
found that inhibiting reproduction with FUdR at standard laboratory 
concentrations improves protein homeostasis, stress resistance and healthspan of 
C. elegans (paper III).  
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1 INTRODUCTION 
 
1.1 C. elegans 
Caenorhabditis elegans is a facultative self-fertilizing nematode 
hermaphrodite with a mean lifespan of ~18 days at 20°C. One self-fertilizing 
animal produces over 300 progeny over the course of 4-5 days and completes a 
full lifecycle in as little as 3 days. The adult animal consists of only 959 somatic 
cells composing many structures and organs including a completely mapped 
nervous system of 302 neurons (Riddle et al., 1997; White et al., 1986). The 
transparency of the animal is particularly useful, as one can use fluorescent 
reporters to visualize many biological processes in vivo. The N2 laboratory strain 
of C. elegans has long been defined as the wild-type reference and it can easily 
be cultured on agar plates with a bacterial lawn of E. coli as a food source. 
Moreover, freezing provides a convenient method of storing stocks of worms . 
Stocks have remained viable for decades in liquid nitrogen or at -80°C which 
minimizes the problem of laboratory deviation of WT by spontaneous mutations 
including transposition events.  
Since its introduction by Sydney Brenner in 1973 (Brenner, 1973), C. 
elegans has emerged as a powerful model organism with many attributes 
applicable to genetic and biomedical research. From the study of the genetics of 
behavior to gene regulation, cell signaling and neuronal development it has also 
become a crucial avenue for studying the genetics and biology of aging (Hekimi 
et al., 2001; Kenyon, 2010; Lithgow et al., 1994). The entire genome of C. 
elegans has been sequenced and in addition to the many mutant strains available, 
RNA interference (RNAi) provides a fast and simple means of reducing the 
expression of specific genes. In short, RNAi is an endogenous post 
transcriptional gene silencing mechanism  triggered by the presence of double-
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stranded RNA (dsRNA).  In C. elegans dsRNA is generally introduced into the 
animal through feeding.. Once inside the animal, the enzyme Dicer cleaves 
dsRNA into shorter dsRNA fragments. After the passenger strand is degraded, 
the guide strand is incorporated into the RNA-induced silencing complex 
(RISC). RISC aids in the pairing of the guide strand with a complementary 
mRNA which is then also cleaved by RISC. Because this process is catalytic and 
contains associated machinery for propagation and extracellular transport in C. 
elegans one only needs to introduce small amounts of dsRNA for efficient 
knockdown of a targeted gene. Andrew Fire and Craig C. Mello were awarded 
the Nobel Prize in Physiology or Medicine for characterizing RNA interference 
(RNAi) in C. elegans. In addition to genetic tractability, many different 
manipulations make C. elegans particularly suitable for aging research. For an 
example, the nematodes environment can easily be manipulated with the 
addition of chemical compounds or with various food concentrations. 
Furthermore, culturing of C. elegans is relatively inexpensive in contrast with 
notoriously expensive mice aging research.  
 
1.2 AGING  
In humans, aging is the leading risk factor for many debilitating disorders 
such as cardiovascular disease, cancer and dementia. These disorders are not 
only socially deleterious, but also extremely costly. The total estimated 
worldwide cost of dementia alone is $604 billion in 2010 (Reisberg et al., 1997). 
The global population is aging at a rapid pace, with an estimated 13 countries 
being designated as “super-aged” in 2020 with more than 20% of the population 
over 65. This number is expected to rise to 34 countries by 2030 according to 
Moody’s Investor Service. This unprecedented pace of global aging will 
undoubtedly have a significant effect on the economic output over the years. The 
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current challenge is to prevent the chronologically aging population from 
becoming a global economic crisis. It is crucial that aging research keep 
advancing so that the dependency ratio of the human population is kept as low as 
possible.  
Aging is characterized as an entropic breakdown of biological function 
on most, if not all levels. The biology of aging was long thought to be a random, 
passive event caused by stochastic deterioration and consequently difficult to 
control. However, discoveries predominantly made in C. elegans have revealed 
aging as a highly plastic process and several signaling pathways and 
transcription factors determine longevity (Johnson, 2006; Johnson et al., 1984; 
Kenyon et al., 1993). Interestingly, many of these pathways and their effect on 
lifespan have been shown to be evolutionary conserved (Kapahi et al., 2010; 
Kenyon, 2001). C. elegans display a number of age-related changes reminiscent 
of higher organisms, including humans. For example, worms become less motile 
with age, have reduced feeding as measured by pharyngeal pumping (Huang et 
al., 2004) and accumulate insoluble protein (David et al., 2010; Herndon et al., 
2002; Reis-Rodrigues et al., 2012). Thus, discoveries of the aging process in C. 
elegans can serve as a platform for research in interventions on human aging.  
1.2.2 Manipulation of lifespan in C. elegans  
C. elegans lifespan can be manipulated via several known genetic 
pathways (Murakami et al., 2000). The first lifespan modulator gene identified in 
C. elegans, age-1, belongs to the insulin-signaling like pathway which is a 
nutritional response program. The age-1(hx546) mutant has a life expectancy 
65% longer than WT. Age-1 mutations have little effect on fertility, length of 
reproduction and rate of development. The mutants are also resistant to various 
stressors such as excess heat and paraquat (frequently used as an oxidative 
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stressor in C. elegans). Another famous gerontology gene, daf-2 was identified 
to have a role in aging in 1993. The DAF-2 receptor lies upstream of age-1 and 
bears structural homology with the human insulin/ IGF type receptors. Thus, a 
daf-2 mutation also results in a robust lifespan extension, which was found to be 
dependent on transcription factor DAF-16 (Kenyon et al., 1993). Under 
favorable conditions DAF-16 is ultimately inhibited by AGE-1 and prevented 
from nuclear localization. During absence of nutrients or unfavorable conditions, 
AGE-1 does not signal to phosphorylate DAF-16, which subsequently enters the 
nucleus to activate many longevity responses. As expected, mutations in daf-16 
lead to a shortening of lifespan.  
Many other genetic programs influence survival in C. elegans. The 
disposable soma theory proposes that the energy expenditure for reproduction is 
costly for the organism in that it diverts resources from somatic cells and thus 
accelerates aging (Kirkwood and Holliday, 1979). In line with this hypothesis, 
the loss of germline precursor cells in C. elegans results in animals lacking a 
gonad and interestingly, an extension of lifespan. This lifespan extension is 
thought to result from a reallocation of resources to somatic cells and it requires 
DAF-16-mediated regulation of fat metabolism (McCormick et al., 2012; 
O'Rourke et al., 2009). The entire reproductive system of adult C. elegans is 
produced by the progeny of four precursor cells present in the first larval stage, 
Z1-Z4  (Kimble and White, 1981). The outermost cells; Z1 and Z4 give rise to 
the somatic gonad (uterus, spermatheca and other somatic tissues) while Z2 and 
Z3 are germ-cell precursors. The hermaphrodite germline includes mature sperm 
and ova with differentiating gametes and totipotent germline stem cells (GSCs). 
Two cells of the somatic gonad also give molecular signals that promote GSC 
proliferation (Schedl, 1997). The removal of the germ-cell precursors Z2-Z3 
results in a large increase in lifespan of worms (Hsin and Kenyon, 1999). 
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Interestingly, animals eliminated of Z1-Z4 entirely lack a gonad but are not long-
lived. Thus, the somatic gonad also signals to influence longevity. This germline 
signaling has been shown to modulate lifespan in worms, flies and possibly mice 
(Flatt et al., 2008; Hsin and Kenyon, 1999). In addition to removal of specific 
germline-precursor cells, there are mutations resulting in germline elimination. 
The germline is removed in glp-1 mutants (Austin and Kimble, 1987) and 
lifespan is extended because of removal of totipotent GSCs that normally 
produce cues that inhibit longevity (Arantes-Oliveira et al., 2002).  
A reduction in nutrients can also extend the lifespan of C. elegans. 
Depending on the type of dietary restriction (DR), various “longevity pathways” 
are involved. A reduced calorie intake, complete absences of food or alternative 
day feeding all seem to act by various pathways to extend lifespan (Greer and 
Brunet, 2009). In addition to food manipulation, there are genetic means to 
induce DR. Mutations which culminate in reduced food intake are called eat 
mutations. Many eat mutations cause reduced pharyngeal pumping and thus lead 
to dietary restriction and increase in lifespan. One can also mimic dietary 
restriction with molecular compounds. For an example, we previously described 
a conserved dietary-longevity signaling pathway that can be modulated 
pharmaceutically (Lucanic et al., 2011).  
DR signaling pathways are by no means exclusive to pharmaceutical 
intervention. Well over 70 compounds have been demonstrated to extend 
lifespan in C. elegans by various mechanisms of action (Lucanic et al., 2013; Ye 
et al., 2014). Many compounds that extend lifespan in C. elegans are FDA 
approved and are widely used in human pharmacology including aspirin (Wan et 
al., 2013), vitamin E (Harrington and Harley, 1988) and lithium (McColl et al., 
2008). There is a wide class of compounds that promote longevity in C. elegans 
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with mechanisms including stress-resistance, autophagy, DAF-16-dependency, 
antioxidant properties, hormesis, proteostasis and TOR-dependency. The target 
of rapamycin (TOR) pathway is a major, highly conserved nutrient-sensing 
pathway that, when down-regulated lead to lifespan increase in worms, flies and 
mice (Bjedov et al., 2010; Chen et al., 2013; Selman and Partridge, 2012; Spong 
and Bartke, 2012; Wilkinson et al., 2012). It is named after the drug rapamycin, 
which inhibits the central component of the pathway.  
Metformin is another drug that has been shown to extend lifespan in C. 
elegans. There are several mechanisms suggested for metformin-mediated 
lifespan extension in C. elegans. Early reports suggested that metformin 
improves healthspan and lifespan by activating DR and antioxidant defense 
longevity pathways (Onken and Driscoll, 2010) but it has also been shown to 
alter folate and methionine metabolism in the bacterial food source, thereby 
extending lifespan (Cabreiro et al., 2013). Another suggested mechanism of 
metformin is a hormetic response, in which metformin-induced production of 
ROS increases lifespan (De Haes et al., 2014). Indeed, mounting evidence 
suggests that multiple mechanisms of action of pharmaceuticals might be the 
norm, rather than the exception (Imming et al., 2006) and C. elegans provides an 
excellent platform in which to identify and investigate compounds that can be 
further explored for beneficial effects on aging in mammals.  
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Table adapted from (Lucanic et al., 2013) 
 
 
 
Table 1. Example of the diversity of compounds that increase lifespan in C. elegans !
 
Compound 
 
Type of Compound 
 
Potential mechanism 
Tocotrienol  Natural product Antioxidant 
EUK-8/EUK134c Synthetic Stress resistance 
Tamarixetin Natural flavonoid Stress resistance 
Resveratrol Natural product Stress resistance, 
autophagy, TOR 
Ethosuxumide Synthetic, 
anticonvulsants 
Serotonin dependent, DR 
Blueberry extract Natural product HSR, osmotic pathway 
Cocoa  Natural product Antioxidant, metal 
chelator 
Lipoic Acid  Natural metabolite Stress resistance 
Valproic acid Synthetic psychoactive DAF-16 dependent 
Acetic acid Reagent, natural product DAF-16 dependent 
Catechin Natural flavonoid DAF-2, NHR-8, MEV-1 
dependent 
Spermidine Natural polyamine Becline-1 dependent 
Trehalose Natural disaccharide Stress resistance, DAF-
16 dependent 
Metformin Biguanide, antidiabetic DR mimetic, SKN-1 
dependent 
Thioflavin T Synthetic, benzothiazole Protein homeostasis 
Curcumin Natural product Protein homeostasis 
CaEDTA, EDTA Synthetic  Metal chelator, protein 
homeostasis 
Diallyl trisulfide Natural product SKN-1 dependent 
Royal jelly Natural product DAF-2/DAF-16 
dependent 
Vitamin E Natural product Antioxidant 
LiCl Chemical mood stabilizer GSK-3 and LSD-1 
dependent 
Damask Rose extract Natural product Antioxidant 
Rapamycin Natural product TOR 
Astragalan Natural product DAF-16 dependent 
Reserpine Natural product Stress resistance  
Celecoxib Synthetic COX2 inhibitor DAF-16 dependent 
Oxaloacetate Krebs cycle metabolite DAF-16/AMPK/ 
dependent !
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1.3 PROTEIN AGGREGATION 
Proteins typically fold into specific three-dimensional conformations 
after synthesis. This native state is imperative for the functionality of the protein 
and a misfolded protein will be more likely to aggregate, often due to 
hydrophobic residues being improperly exposed. Therefore, the biological 
pathways within cells that control the biogenesis, trafficking, folding and 
degradation of proteins are critical for overall cellular and organismal 
functionality and survival.  
Organisms respond to insults such as heat, oxidative stress and 
environmental toxins by activating transcriptional and post-transcriptional 
programs that promote proteostasis. Molecular chaperones are proteins that assist 
the non-covalent folding or unfolding of macromolecules. In many cases, 
chaperones prevent newly synthesized proteins from misfolding into non-
functional structures. Heat Shock Proteins (HSPs) are a class of chaperones 
induced upon thermal stress. Many HSPs are activated by various stressors that 
otherwise cause aggregation (Li and Srivastava, 2004; Wu, 1995). In addition to 
molecular chaperones, the ubiquitin-proteasome pathway (UPP) plays a major 
role in maintaining proteostasis (Goodsell, 2003; Hershko and Ciechanover, 
1982). The UPP degrades misfolded proteins in two well-characterized steps; 
tagging of the substrate protein with ubiquitin molecules and degradation of the 
tagged protein by the proteasome (Ciechanover et al., 1980; Haas et al., 1982; 
Hershko et al., 1980; Pickart and Eddins, 2004). In this manner the UPP controls 
the timed destruction of cellular proteins and allows for recycling of 
oligopeptides. When chaperone activity and the UPP are not sufficient at 
restoring proteostasis a more global disruption to protein folding ensues. In these 
scenarios the Unfolded Protein Response (UPR) is activated. The UPR is a 
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highly conserved pathway that is triggered by an accumulation of misfolded or 
aggregated proteins in the lumen of the endoplasmic reticulum. The UPR 
activates three mechanisms; first it halts protein translation as to reduce buildup 
of aggregates, secondly it works to degrade misfolded proteins and activate 
chaperones. Lastly, if balance is not restored, the UPR can initiate apoptosis. The 
mitochondrial unfolded protein response (UPRmt) is a conceptually similar 
stress-response pathway that activates transcription of mitochocondrial 
chaperone genes to promote proteostasis within the mitochondrion. 
1.3.2 Protein Aggregation in Disease 
There are numerous causes for protein aggregation. Several known 
mutations cause improper aggregation-prone tertiary structures and result in 
accumulation of aggregates. A failure in the chaperone network or the ubiquitin-
proteasome pathway due to aging and/or metabolic and environmental stressors 
can exacerbate proteostasis-related disease (Forsberg et al., 2010; Jansen et al., 
2014; Rodriguez et al., 2014). Thus, many aggregation-related disorders are also 
aging diseases.  
Alzheimer’s Disease (AD) is the most common form of dementia and 
there is no cure to date. Roughly 30 million people suffer from AD in the world 
and it is predicted to affect 1 in 85 people by 2050 (Brookmeyer et al., 2007). 
The neuropathological hallmarks of AD are neurofibrillary tangles (NFT) and 
plaques composed of amyloid peptide (Aβ) processed from the amyloid 
precursor protein (APP). APP is a neuronal transmembrane protein that is critical 
to neuron growth and post-injury repair (Kamenetz et al., 2003; Korte et al., 
2012; Young-Pearse et al., 2008). In AD, APP is divided into smaller fragments, 
some of which give rise to Aβ fibrils that form extracellular senile plaques 
(Tiraboschi et al., 2004). Aβ is neurotoxic at non-physiological concentrations in 
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vitro and Aβ1-42 is known to rapidly self-aggregate in solution (Hilbich et al., 
1991; Jarrett et al., 1993). The overproduction of Aβ is often regarded as the 
major contributor to the disease and evidence point toward the soluble, but not 
the fibrillar forms, as the cause for the pathology (Lue et al., 1999; McLean et 
al., 1999). In addition to Aβ plaques, AD brains also contain tau aggregates. Tau 
is a microtubule-associated protein that normally stabilizes the cytoskeleton and 
fosters the neuronal transport system. Tau is hyperphosphorylated in AD, 
creating sticky threads that culminate in neurofibrillary tangles and a disruption 
of microtubular transport (Mendoza et al., 2013). The prognosis for AD patients 
is poor. The symptoms generally progress from mild short-term memory loss to 
severe cognitive problems that render the individual dependent on full-time care. 
In addition to cognitive decline, AD is also accompanied by psychological 
effects such as depression, irritability and aggression (Burke et al., 1988; Burns 
et al., 1990; Shuttleworth et al., 1987). Therapies for AD include behavioral 
interventions but the majority of diagnosed patients are on pharmaceutical 
medications. Two classes of medications are in use for AD; a range of 
acetylcholinesterase inhibitors and one NMDA receptor antagonist. The 
acetylcholinesterase inhibitors lead to an increase in acetylcholine which is 
decreased in AD brains, and the NMDA receptor antagonist inhibits glutamate 
overstimulation and resulting excitotoxicity (Lipton, 2006). Both classes of 
drugs are only moderately effective in advanced stages and neither has proven to 
delay onset of the disease (Raina et al., 2008).  
Huntington’s Disease (HD) is a neurodegenerative genetic disorder 
causing cognitive decline, muscle twitching (chorea) and behavioral symptoms. 
HD is quite unique among age-related ND in that all cases are caused by 
mutation in a single gene for which genetic testing is available (Reilmann et al., 
2014). HD is caused by mutation of the HTT gene, producing excessive CAG 
  11 
trinucleotide repeats. Thus, HD belongs to the polyglutamine tract (polyQ) 
disease family. PolyQ is subject to increased aggregation and a progressive 
degeneration of nerve cells with age is a common pathology of PolyQ diseases. 
Symptomatic treatment options for HD include dopamine receptor antagonist 
that reduce dopamine levels but long-term use of these drugs have adverse 
effects and are not beneficial in later stages of HD. 
Parkinson’s Disease results in debilitating motor symptoms, which are 
collectively called Parkinsonism (Pilger et al.). The disease is idiopathic but as 
with AD, there are controversial reports of risk factors such as exposure to 
environmental toxins (Tanner et al., 2014). PD is characterized by the 
accumulation of alpha-synuclein and other proteins into Lewy bodies, 
proteinaceous aggregates within dopamine cells in the substantia nigra region of 
the brain. The mechanism behind formation of Lewy bodies is unclear but it 
seems that impairment of the UPS could be partially responsible (Feany and 
Bender, 2000; Masliah et al., 2000). Treatments of PD include levodopa and 
dopamine agonists that are effective at managing the early motor dysfunctions 
caused by the decline in dopamine. Unfortunately, in later stages of the disease 
drugs are ineffective and can contribute to dyskinesia, the involuntary twitching 
often displayed by PD patients.  
1.3.3   C. elegans Models of Proteotoxic Disease 
In addition to serving as a platform for studying the genetics of normal 
aging, C. elegans has become useful for the study of age-related aggregation 
disorders. The worm genome contains homologs of two-thirds of all human 
disease genes (Remm and Sonnhammer, 2000; Sonnhammer and Durbin, 1997) 
and transgenic animals have been created to express human peptides to study the 
formation of aggregation in vivo. Several AD models have been created by 
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transgenic expression of the human Amyloid β protein in C. elegans (Lublin and 
Link, 2013; McColl et al., 2012; Minniti et al., 2009). For example, 
CL4176[smg-1(cc546ts); dvIs27(myo-3::Aβ3–42 let 39UTR(pAF29))] is a strain 
expressing the human Aβ peptide in the body wall muscle which form 
intracellular aggregates (Drake et al., 2003). It is a temperature-sensitive strain in 
which Aβ is expressed in muscle upon a temperature upshift, leading to eventual 
paralysis of the animal. The paralysis phenotype provides a straightforward read-
out when assessing a drugs effect on Aβ aggregation or toxicity. In addition, the 
Aβ aggregates can be visualized by immunohistochemistry and quantified by 
western blot (Minniti et al., 2009).  
There are also HD worm models, including strain 
AM141[rmIs133(P(unc-54) Q40::YFP)] in which an extended polyglutamine 
stretch is expressed in the muscle of the animal  (Morley et al., 2002). 
Expression of a huntingtin fragment containing polyQ expansions leads to 
protein aggregate formation, easily visualized by the yellow fluorescent protein 
(YFP) tag. This model can be used to address the effects of compounds on 
polyglutamine expansions by quantifying the number of aggregates by 
microscopy or by assessing the functional physiology of the animals by 
measuring movement. HE250 [unc-52(e669su250)II]) is a strain expressing a 
metastable mutant perlecan protein. Perlecan is a heparin sulfate proteoglycan 
core protein of the mammalian basement membrane. In HE250, perlecan 
misfolds, resulting in destabilization of muscle tissue with ensuing paralysis 
(Mackenzie et al., 1978). In contrast to the more specific AD and HD model 
strains, HE250 is used as an indicator of the general protein homeostatic network 
capacity (Gidalevitz et al., 2006). 
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  A                                                                     B       
                                       
Figure 1. Paralysis phenotype in C. elegans model of proteotoxic disease                                             
A) Adult HE250[unc-52(e669su250)II] exhibiting normal movement                           
B) Adult HE250[unc-52(e669su250)II] paralysis phenotype after 25°C upshift 
 
1.3.4   Proteomic Studies in C. elegans 
In addition to models of ND, one can employ a global approach in 
identifying and quantifying aggregation-prone proteins in C. elegans. Proteins 
such as tau and Aβ have long been separated using strong detergent buffers. The 
aggregation-prone property of these proteins renders them insoluble in most 
buffers but subsequent solubilization is possible with strong acids. A similar 
approach can be used to quantify insoluble proteins in C. elegans. One can 
visually analyze this ‘insolublome’ on SDS-PAGE gels and further identify and 
quantify the fraction using mass spectrometry-based proteomic analysis. Once 
the aggregation-prone proteins are identified utilization of software such as 
DAVID (The Database for Annotation, Visualization and Integrated Discovery) 
allows for discovery of common functional or structural features (Huang da et 
al., 2009) 
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1.3.5 Protein Aggregation: An Aging Hallmark 
As many protein aggregation-associated diseases increase in frequency 
with age, it seems clear that cells generally lose the ability to maintain 
proteostasis over time. The imperative functions of protein degradation and 
disposal as well as chaperone efficiency all decline with age (Cuervo and Dice, 
2000; Lund et al., 2002; Tonoki et al., 2009). Aging is also accompanied by an 
increase in oxidative stress, resulting in modifications such as oxidation and 
nitration, ultimately contributing to an increase in protein aggregation (Poon et 
al., 2006; Squier, 2001). We and others have shown that aging of C. elegans 
results in an accumulation of insoluble proteins, limiting the lifespan of the 
organism independent of a particular disease state (David et al., 2010; Reis-
Rodrigues et al., 2012). Therefore, multiple lines of evidence suggests that 
protein aggregation is a key pathological feature of the aging process.  
Interestingly, many transcription factors and responses that regulate 
proteostasis also govern aging in C. elegans. For example, overexpression of 
UPR mediator XBP-1 increases longevity (Taylor and Dillin, 2013) while a 
reduction of the IRE-1/XBP-1 UPR branch shortens the long lifespan caused by 
reduced IIS in C. elegans (Henis-Korenblit et al., 2010). Furthermore, a 
reduction in IIS provides protection from toxic protein aggregation (David et al., 
2010). This protection is dependent upon both DAF-16 and HSF-1(Hsu et al., 
2003; Morley and Morimoto, 2004). HSF-1 is a conserved transcription factor 
which upregulates the transcription of many chaperone genes in response to heat 
stress. This Heat Shock Response (HSR) is crucial in maintaining proteostasis 
during exposure to environmental stressors. Notably, overexpression of hsf-1 
extends lifespan in C. elegans (Hsu et al., 2003) as does overexpression of HSF-
1 target genes hsp-16 and hsp-70 in both C. elegans and D. melangaster. 
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(Khazaeli et al., 1997; Walker and Lithgow, 2003; Walker et al., 2001). Much 
like a reduction in IIS, DR also fosters proteostasis and has been found to 
promote protection from Aβ aggregation via HSF-1 activity (Steinkraus et al., 
2008). There are such numerous examples of lifespan governing mechanisms 
playing a role in proteostasis and vice versa that it indeed would seem as if 
proteostasis and longevity, at least in part, depend upon each other. 
1.4 METALS  
Many metals function as osmolytes, structural fulcrums and signal 
transduction agents. As such, they are required cofactors for an estimated one 
quarter to one third of the human proteome and are involved in key biological 
processes including respiration, gene regulation, DNA replication and 
neurotransmission (Lippert, 1992; Osterberg, 1974; Williams, 1988). Copper is 
an essential trace metal with a crucial role in mitochondrial respiration and 
neurotransmission (Opazo et al., 2014). 
In addition, a family of copper-dependent amine oxidases functions in 
determining the integrity of connective tissues (Turski and Thiele, 2009). 
Manganese is an essential component of human Mn-superoxide dismutase, 
pyruvate decarboxylase and glutamine synthase (Christianson, 1997) but is 
seemingly interchangeable with either magnesium or zinc in most processes 
(Andreini et al., 2008). Iron is the most active metal used in biological systems 
and is most famous for being part of heme moieties; the oxygen carriers in 
proteins such as hemoglobin (Tsiftsoglou et al., 2006). Iron-sulfur clusters are a 
chemical species utilized in a wide range of processes such as the mitochondrial 
electron transport chain, the TCA cycle and gene expression. 
Conversely to copper, manganese and iron, non-biologically essential metals 
(e.g. aluminium, cadmium, mercury) often act to disrupt normal metabolism and 
cause numerous types of toxic effects (Kozlowski et al., 2014).  
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1.4.2 Iron Homeostasis in C. elegans 
Iron is essential in primary life functions for all eukaryotes due to its use 
as an electron donor and acceptor. The most abundant and stable oxidation states 
of iron are Fe2+ and Fe3+, which are readily convertible. The ability of iron to 
satisfy redox potential reactions is what makes it absolutely essential for life, 
however, this property is also a detriment. Fe2+ reacts with oxygen intermediates 
such as H2O2 to produce highly reactive free radical species. In turn, the 
reduction of Fe3+ regenerates the active form of Fe2+ that can re-enter the redox 
cycling with the continuous deleterious production of free radicals in the Fenton 
reaction chain(Stohs and Bagchi, 1995). Therefore, the tight regulation of iron is 
imperative for the health of the organism.  
 
Fe2+ + H2O2 à Fe3+ + OH + OH-                Fenton Reaction 
                                                                             
Fe3+ + O2- à  + Fe2+ + O2 
 
C. elegans are heme auxotrophs and are as such dependent on acquiring 
heme from the environment (Rao et al., 2005). C. elegans iron export is 
facilitated by ferroportins FPN-1.1, FPN-1.2 and FPN-1.3 which shuttles iron to 
the interstitial space while iron import is facilitated by a mammalian DMT-1 
ortholog; SMF-3. SMF-3 is highly expressed in the intestinal epithelium (Au et 
al., 2009) and is transcriptionally activated during iron deficiency to restore 
balance (Romney et al., 2011). 
The control of iron availability in the cells is largely dependent on 
ferritins, ubiquitous proteins with iron storage and detoxification capacity. In 
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mammals, cytosolic ferritins are composed of two types of subunits, the Heavy 
and the Light chain, forming a spherical cage. Heavy chain ferritins (H-ferritins) 
contain a ferroxidase center which has the oxidation capacity to alter Fe2+ to 
Fe3+(Lawson et al., 1989). In mitochondria, ferritin is present in the form of a 
complex with 24 identical chains (Finazzi and Arosio, 2014). C. elegans have 
two forms of H-ferritin genes, ftn-1 which is predominantly expressed in the 
intestine and ftn-2 which is expressed in most cell types (Kim et al., 2004; 
Romney et al., 2008). Similarly to mammalian H-ferritin, both FTN-1 and FTN-
2 contain ferroxidase active-site residues (Gourley et al., 2003). The organism 
regulates its iron storage capacity in response to its environment; iron chelation 
decreases ftn-1 expression and iron supplementation increases ftn-1 expression. 
As expected, ftn-1 mutants are sensitive to iron exposure (Kim et al., 2004; 
Valentini et al., 2012).  
Intriguingly, known lifespan and healthspan modulators are involved in 
ferritin regulation in C. elegans. The hypoxia-inducible factor (HIF-1) plays a 
role in oxygen homeostasis, tumor formation, cell survival and the inflammatory 
response. It is also a known lifespan modulator in C. elegans as stabilization of 
the HIF-1 protein extends longevity (Leiser et al., 2011; Leiser and Kaeberlein, 
2010; Mehta et al., 2009; Zhang et al., 2009). Hif-1 also plays a role in iron 
homeostasis, as HIF-1 transcriptionally inhibits ftn-1 and ftn-2 during iron 
deficient scenarios. 2’2-Bipyridine (BP) is an iron chelator to which C. elegans 
responds by down regulating ferritin. Hif-1(ia04) mutant animals lack the 
appropriate reduction of ftn-1 and ftn-2 mRNA levels with exposure to BP. In 
addition, constituent expression of HIF-1 results in reduced ftn-1 and ftn-2 levels 
comparable to wild-type animals exposed to BP (Romney et al., 2008).  HIF-1 
also participates in iron homeostasis by activating smf-3 transcription during iron 
deficiency in order to increase iron uptake. In addition to HIF-1, DAF-16 has 
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been shown to modulate iron levels in C. elegans as long-lived daf-2 mutants 
show a DAF-16-dependent increase of ftn-1 expression (Ackerman and Gems, 
2012). Increased available iron promotes growth but also increases ROS 
production. Therefore, it is plausible that the IIS regulation of ftn-1 modulates a 
trade-off between growth and stress resistance partly by iron accessibility. 
1.4.3 Metal Imbalances and Neurodegenerative Disease 
Neurodegenerative disorders (ND) share similar pathological features 
and are often associated with disruption in analogous metabolic processes such 
as protein aggregation and oxidative stress, both of which are associated with the 
involvement of metal ions. In addition, these aggregation-related disorders often 
have a more clear-cut association with metals as they frequently are 
accompanied by metal accumulation in the patients’ brain. Copper, manganese 
and iron are all linked to a number of neurological conditions (Danilo Milardi, 
2011).  
Copper has been linked to ND in various ways. The blood serum and 
Cerebral Spinal Fluid (CSF) of patients with AD have significantly higher levels 
of copper compared with age-matched controls (Basun et al., 1991; Squitti et al., 
2002). Copper seems to be abnormally redistributed in AD brain regions with an 
overall reduction in Cu levels and high concentrations in senile plaques (Deibel 
et al., 1996; Loeffler et al., 1996; Lovell et al., 1998). There is some evidence to 
suggest that copper in combination with a high fat diet increases the risk for AD 
(Morris et al., 2006) and small amounts of Cu in drinking water can induce Aβ 
plaques and learning deficits in an AD rabbit model (Sparks and Schreurs, 2003). 
Copper is also implicated in PD. Similarly to AD, plasma levels of PD patients 
contain higher levels of Cu compared with controls (Kumudini et al., 2014) and 
Cu seems to aggravate the aggregation and toxicity caused by α-synuclein 
(Wang et al., 2010). Amyotrophic Lateral Sclerosis is a motor neuron disease in 
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which metals long have been implicated. Copper and other metals have been 
found to be elevated in tissue, serum and bone from ALS patients (Ihara 2005) as 
well. In addition to an involvement in ND, copper homeostasis is perturbed with 
normal aging; plasma copper levels have been reported to increase in blood 
serum and plasma of humans with age (Iskra et al., 1993; Madaric et al., 1994; 
McMaster et al., 1992).   
Manganese has mainly been linked to PD. To date, four PD genes have 
been shown to have a connection with Manganese regulation (Chen et al., 2014). 
Metal related PD hypotheses are also based on a similarity between Mn exposure 
induced neurodegeneration and PD. Specifically, Manganism is a neurological 
disorder that is caused by high exposure to Mn resulting in motor dysfunction, 
cognitive and behavioral problems akin to those of PD. Another class of 
neurodegenerative diseases that are influenced by manganese are prion 
misfolding diseases.  Prions cause neurodegeneration by aggregating and 
forming extracellular amyloid plaques in the CNS and manganese levels have 
been shown to be elevated in patients with prion disease as well (Thackray et al., 
2002).  
1.4.4 Iron and Neurodegenerative Disease 
In addition to extracellular plaques and intra-neuronal tangles, AD is 
accompanied by an impaired ubiquitin-proteasome system and increased 
oxidative stress (Mandel et al., 2007). Iron accumulates in specific regions of AD 
patients’ brains, with higher concentrations in the hippocampus and cerebral 
cortex (Danilo Milardi 2011). The high oxidative buildup in AD neurons could 
be explained by the iron surplus in these regions as histo-chemical studies have 
shown that there is a presence of Fe2+ deposits and Fe3+ in senile plaques and 
neurofibrillary tangles of AD patients (Smith et al., 1997). Iron overload 
increases production of both APP and Amyloid β in mice, and chronic iron 
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treatment causes accelerated cognitive impairment in transgenic mice model of 
AD (Becerril-Ortega et al., 2014). Furthermore, in vitro studies have also shown 
that iron can induce the formation of neurotoxic fibrils of Aβ (Bush, 2003).  
In addition to the pathological involvement of iron in AD, there is a 
regulatory relationship between iron levels and Aβ as iron has been found to 
modulate the expression of APP through an iron-responsive element (IRE) in its 
5’ UTR (Avramovich-Tirosh et al., 2008). This pathway has been investigated as 
a potential avenue for pharmaceutical treatment of AD patients and several iron 
chelators have been found to suppress Aβ accumulation by modulating 
translation of APP (Danilo Milardi, 2011; Venti et al., 2004). However, the 
mechanism of Aβ-mediated toxicity remains elusive as large amounts of amyloid 
plaques have been observed with minor neuronal alterations in both mouse AD 
models and human aging brains suggesting that Aβ accumulation alone is not 
sufficient to drive AD (Danilo Milardi, 2011). Indeed, in what has been 
speculated as a compensatory neuroprotective response, Aβ possesses iron-
binding sites, which subsequently would lower the generation of ROS. The 
complicated relationship between iron and Aβ in neurodegeneration is unclear 
and requires further investigation.  
Parkinsonian brains have elevated levels of iron in microglia, astrocytes, 
oligodendrocytes and dopaminergic neurons (Gaeta and Hider, 2005). The 
degeneration of the substantia nigra region in PD could be attributed to oxidative 
stress; there is an abnormal accumulation of reactive iron in this region of PD 
patients’ brains as well (Faucheux et al., 2003; Zecca et al., 2004).  In addition to 
a perturbation of overall iron levels, there is also an abnormal distribution of Fe2+ 
to Fe3+ ratio associated with PD. Post mortem parkinsonian brains have higher 
levels of reactive Fe2+ compared with controls (Sofic et al., 1988). Interestingly, 
a reduction in reactive iron by either genetic or pharmacological means has been 
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found to result in protection against Parkinson-inducing toxin 1-methyl-4-
phenyl-1,2,3,6-tetrapyridine (Kaur et al., 2003) suggesting that iron chelation 
might be a potential therapy for PD.  
AD and PD are not the only neurodegenerative disorders in which 
perturbed iron homeostasis is involved. There are more direct examples of iron 
accumulation as a causative factor in ND. Ferritin mutations can cause human 
disorders by perturbing iron homeostasis. Neuroferritinopathy is such a disease 
and is mainly characterized by chorea, tremor and ataxia but cognitive decline 
has also been reported (McNeill and Chinnery, 2012). The disorder is thought to 
be caused by cerebral iron accumulation particularly in the basal ganglia 
(Crompton et al., 2002). Another example is the autosomal dominant disease, 
aceruloplasminemia. It is caused by a mutation in the Cp gene which results in 
the complete absence of Cp ferroxidase activity. The inability to oxidize Fe and 
remove its excess results in peroxidation and ROS formation within the cell, 
ultimately causing severe CNS degeneration. 
 
1.4.5 Elemental Analysis in C. elegans 
Inductively coupled plasma-atomic emission spectroscopy (ICP-AES) is 
a well-established method of measuring the levels of elements in a sample by 
exploiting the fact that thermally ionized atoms emit characteristic photons at 
given wavelengths when the electrons within the atom transition from excited to 
ground states. The instrument measures the intensity of photon yield at specific 
calibrated wavelengths for each element of interest and then quantifies the 
elemental composition within the unknown sample using reference standards. A 
stable plasma of ~7000 °K is generated using neutral argon which is ionized by 
an intense electromagnetic field within a high-intensity radio frequency coil. The 
rate of release of new electrons in collision is balanced by the rate of 
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recombination of electrons with argon ions to generate the stable plasma. The 
sample is then introduced into the plasma through a nebulizer and carried by an 
argon carrier gas flow. Photons from the ionized sample are collected at either 
axial or radial angles, directed through the instrument via prisms and mirrors, 
and rastered onto a charge-coupled device (CCD) with solid-state sensors for 
wavelengths from infrared to ultraviolet electromagnetic energy. Other elements 
for weak electronegative ionization suppression (cesium) and internal standard 
measurement (yttrium) are run in-line with unknown samples. A robotic 
autosampler assists in the delivery and wash-out between each sample 
(Boumans, 1987).  
ICP-AES analysis requires a sample to be in solution. For our purposes, 
we prepared C. elegans material by washing off large cultures of synchronous 
populations and determining the dried weight of samples before acid digestion 
and subsequent dilution. Once the concentrations were analyzed, we normalized 
the values for dry weight and could thus determine elemental composition of 
young versus old animals, as well as animals subjected to treatment with the 
metal chelator, EDTA.  
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2 AIMS 
 
The overall objective of this thesis has been to elucidate the relationship 
between protein aggregation and aging by utilizing compounds with varied 
mechanisms of action in stabilizing proteostasis in C. elegans. 
 
Specifically 
Paper I: First, investigate whether known aggregation-binding molecules can 
slow aging in C. elegans. Secondly, investigate if the compounds inhibit protein 
aggregation in vivo through examination of the chemical’s effects on C. elegans 
models of proteotoxic disease and ultimately investigate if known longevity 
modulator genes are required for the compounds’ efficacy.  
Paper II: Examine the metallome with age to elucidate any endogenous changes 
in metal levels. Subsequently, investigate whether iron, which was found to 
accumulate with age, can drive protein aggregation and aging phenotypes. 
Thirdly, investigate if pharmacological reduction of the iron load slows protein 
aggregation, and ultimately aging. 
Paper III: Screen a 640-compound natural-product library for additional small 
molecules that could slow protein aggregation. One of the strongest hit in our 
paradigm was analogous to a drug frequently used in C. elegans research; FUdR. 
We therefore sought to investigate if FUdR protects the proteostatic network and 
thereby influence healthspan and lifespan.   
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3 RESULTS AND DISCUSSION 
 
3.1 PAPER I: Amyloid-binding compounds maintain protein homeostasis during 
ageing and extend lifespan. 
Protein homeostasis has been shown to be a critical component of 
longevity through extensive genetic studies. For an example, proteostatic 
stabilization by overexpression of chaperones or transcription factors can extend 
lifespan in C. elegans. Pharmaceutical means of promoting proteostasis could 
therefore provide a useful tool in treating age-related diseases. We reasoned that 
compounds with known protein-fibril and protein-aggregate-binding properties 
could affect age-related changes to protein homeostasis and possibly slow aging. 
In order to test this hypothesis, we investigated compounds traditionally used in 
histopathology to stain amyloid tissues and bind protein fibrils in vitro and in cell 
culture. In this paper, we were indeed able to show that exposure of adult C. 
elegans to compounds that promote proteostasis can prolong health- and 
lifespan. 
First, we investigated the effects of exposing adult C. elegans to the 
fibril-binding dye flavonoid ThT (4-(3,6-dimethyl-1,3-benzothiazol-3-ium-2-yl)-
N,N-dimethylaniline chloride). We found that exposure to 50 µM or 100 µM 
ThT throughout adult lifespan increases median lifespan by 60% and maximal 
lifespan up to 78%. Although lifespan is a common measurement in aging 
research one could argue that healthspan might be of greater importance.           
C. elegans exhibits a decline in movement with age and the vigor of the animal 
can be measured in the number of body bends within a given timeframe. We 
investigated the effects of the compounds on healthspan by measuring 
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spontaneous movement throughout adulthood. Exposure to ThT at 
concentrations that extend lifespan slowed age-related decline in movement, 
suggesting that ThT also extends healthspan of C. elegans.  
In order to investigate the commonality of aggregation-binding 
molecules we asked whether other compounds with similar properties, including 
curcumin and rifampicin also could slow aging and found this to be the case, 
albeit at slightly lower extents compared with ThT. We then asked whether ThT 
and Curcumin act via different mechanisms by combining the treatments and 
found no additive effect of the compounds, suggesting that they act in the same 
pathway/manner to extend lifespan. In order to further confirm that ThT binds to 
aggregation-prone proteins, we performed immunohistochemical assays on 
worms exposed to ThT. Both immunohistochemical and phenotypical data 
showed that ThT significantly suppressed Aβ aggregation, polyQ aggregation 
and WT age-related aggregation of oligomeric protein. In order to improve our 
understanding of the mechanism by which ThT extends lifespan we investigated 
the involvement of genetic pathways by either exposing mutant worm to ThT or 
by utilizing RNAi. A loss of effect in a mutant background suggests that this 
gene is required for the drugs response. HSF-1 and SKN-1 are both transcription 
factors in stress response pathways, involved in stabilization of misfolded 
proteins and lifespan regulation and our findings suggest that ThT depend on 
HSF-1 and SKN-1 for its effect on lifespan.  
This study further solidifies protein aggregation as a detrimental feature 
of the aging process and validates the theory that proteostatic protection extends 
the vitality and life of C. elegans and it illustrates the multifaceted utility of C. 
elegans in basic aging research. Moreover, several life-extending compounds are 
identified which could be further tested in higher organisms such as mice.  
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3.2 PAPER II: Iron promotes protein insolubility and aging in C. elegans 
When we were investigating the effects of compounds with molecular 
similarity to ThT (paper I) we came across several compounds that also extended 
lifespan but at much lower concentrations; 2-(2-hydroxyphenyl)-benzoxazole 
(HBX) and 2-(2-hydroxyphenyl) benzothiazole (HBT). Interestingly, these 
compounds were previously shown to bind divalent metals in addition to Aβ. 
Because we were aware of the involvement of metals in aggregation-related 
disorders, we wanted to investigate the role of metals in proteostasis with age. 
There are several studies that have focused on single metals in the context of 
aging or disease but few that have approached this relationship in an integrative 
way.  
We first aimed to establish a novel picture of aging by studying the 
elemental composition of C. elegans during aging, which would facilitate the 
identification of new targets for age-related therapies. We investigated whether 
the metallome is altered with age in C. elegans by measuring several metals in 
synchronous populations of aged animals with ICP. After determining that iron 
accumulates as a function of organismal aging we asked whether iron 
supplementation could accelerate aging-phenotypes. We discovered that addition 
of iron to the food source leads to acceleration of age-related aggregation 
phenotypes in C. elegans models of AD and HD. After extracting the SDS-
insoluble proteins a mass spectrometry approach allowed us to identify 681 
proteins for control worms and 1068 proteins for iron-treated worms suggesting 
that iron potentiates the tendency of numerous proteins to aggregate. 
Interestingly, we observed a strong similarity in the functional classes of 
aggregation-prone proteins in aged and iron-treated animals, suggesting that iron 
supplementation and aging have very similar effects on protein insolubility. 
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To find out if we could decelerate aging with a reduction of metal load, 
we tried several chelators. In order to screen for bioavailability we measured the 
growth rate and fertility of animals exposed to various chelators. Knowing that 
metals are essential for growth and reproduction we reasoned that we would 
impair these processes if the compounds were bioavailable to the animals. After 
establishing that CaEDTA significantly slowed growth and delayed reproduction 
we went on to investigate if metal content of the animals were altered utilizing 
ICP. Our data suggests that CaEDTA exposure significantly reduces the iron 
load, and to a lesser extent, zinc, in C. elegans. We set out to investigate if a 
reduction in the in vivo iron load would promote proteostasis by utilizing the ND 
C. elegans models that were exacerbated in response to iron. We were able to 
show that exposure to 2.5 mM CaEDTA reduced protein aggregation phenotypes 
in all paradigms tested. Importantly, CaEDTA exposure from day one of 
adulthood not only extended lifespan of WT C. elegans but also improved 
healthspan in a dose-dependent manner.  
Based on these observations we conclude that metal homeostasis is 
perturbed in aging of C. elegans and maintenance of metallostasis could provide 
a useful avenue in maintaining proteostasis with age in other organisms. We also 
deduce that elevated iron levels can lead to an acceleration of several aging 
phenotypes, such as the accumulation of insoluble protein. 
3.3 PAPER III: A DNA Synthesis Inhibitor is Protective Against 
Proteotoxic Stressors via Modulation of Fertility Pathways in Caenorhabditis 
elegans. 
In paper I we investigated the effects of known amyloid-binding 
molecules and found they had advantageous effects on lifespan in C. elegans. In 
order to identify additional compounds with similar effects we screened a library 
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of small molecules in a general model of protein misfolding (HE 250). The 
natural product library that was screened contains 640 small molecules that are 
mostly derived from plant, bacteria, fungi and animal sources. A compelling case 
for natural products is that their activity has been selected for through evolution 
with a reduced rate of cytotoxicity. Based on previous knowledge and findings 
(paper I and II) we reasoned that compounds that slow protein aggregation are 
also likely to extend healthspan and lifespan. 
We identified 5-fluorouridine (FU) as a strong hit and recognized its 
similarity with 5-fluoro 2-deoxyuridine (FUdR). FUdR is widely used in C. 
elegans research and thus we set out to investigate if FUdR also ameliorates 
protein misfolding. We examined the effects of FUdR in the unc-52 mutant 
model HE250 and found that similarly to FU, FUdR significantly inhibited 
proteotoxicity as measured by paralysis in this strain. To determine if FUdR 
confers protection in age-dependent models of aggregation, similarly to 
compounds identified in paper I and II, we again examined the temperature-
sensitive Aβ and PolyQ models, CL4176 [smg-1 (cc546ts); dvIs27(myo-3::Aβ3–
42 let 39UTR(pAF29))] and AM141[rmIs133(P(unc-54) Q40::YFP)], 
respectively. We exposed these animals to FUdR at the L4 stage, during 
spermatogenesis. Together, our data suggests that FUdR confers protection in 
models of protein aggregation by inhibiting fertilization. 
Next, we tested whether FUdR treatment leads to stress resistance. We 
examined the survival of animals exposed to FUdR at higher temperatures and 
also utilized a transcriptional reporter strain, phsp-16.2::GFP, in which GFP is 
under the transcriptional control of the hsp-16.2 promoter (Link et al., 1999). 
Together our data suggests that FUdR may confer thermotolerance in part by 
upregulating the heat-stress response. Loss of germline precursor cells in C. 
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elegans result in sterile animals with improved protein homeostasis and extended 
lifespan. We attempted to validate whether FUdR relies on the germline to 
confer protection by utilizing glp-1(e2141) mutant animals that lack a germline. 
Because previous reports have shown that DAF-16 and DAF-12 (a steroid 
hormone receptor) are required for lifespan extension in animals lacking a 
germline we sought to find out whether FUdR relies on these pathways to confer 
thermotolerance. Our findings suggest that FUdR does not act by inhibiting these 
germline signals, but is acting in an unknown, germline dependent manner. In 
order to determine where in the reproductive pathway FUdR is acting to confer 
stress resistance we examined several mutants deficient in sperm production, 
meiotic maturation of oocytes and ovulation. FEM-3 mutant animals are 
phenotypically female, laying unfertilized oocytes (Doniach and Hodgkin, 1984; 
Hodgkin, 1986). This mutant was found resistant to FUdR treatment, but 
restoration of ovulation (by introduction to WT males) in this strain was 
sufficient to reinstate the effects of the drug. Thus, our data suggest that FUdR 
confers stress resistance by inhibiting oocytic maturation. The observation was 
further validated by studies in which FEM-3 knockdown via RNAi resulted in 
upregulation of the heat shock response as well as protection in the polyQ model 
AM141. 	  
In conclusion, we show that the widely used DNA synthesis inhibitor, 
FUdR is implicated in the heat stress response via a sex-determining pathway. 
Our data suggests a model in which FUdR acts via a germline signal to confer 
protection against proteotoxicity. Furthermore, our findings signify the 
importance of caution while utilizing FUdR in C. elegans research.  
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